Total Funding
39
11
Total FundingSeries A raised
Growth Score
-8 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
35071
Haystack Oncology enables precision oncology to optimize treatment strategies.
- Dan Edelstein: CEOPast Role: Sysmex Corporation, SVP Commercial Operations/COO
- Joel Kaufman: Chief Financial Officer
About the Company
Haystack Oncology, an oncology company, uses the most recent circulating tumor DNA detection technology to enhance the diagnosis of minimum residual disease and provide superior therapy decision-making information.
